OregonRelating to reporting obligations for patient assistance programs for prescription drug purchases.
What it does
Requires prescription drug manufacturers to report to the Department of Consumer and Business Services the total number of consumers to which the manufacturer offered a patient assistance program who participated in the program, notwithstanding any increase in the price of the prescription drug for which the manufacturer offered the program.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Jun 28In committee upon adjournment.Latest
- Apr 9Motion to rerefer to Behavioral Health and Health Care carried. Rereferred.
- Apr 8Rules suspended. Carried over to April 9, 2025 Calendar.
- Apr 7Second reading.Minor
- Apr 7Recommendation: Do pass.Minor
- Apr 1Work Session held.
- Vote recorded Heard and Reported Out. Result: pass.Lower
- Feb 25Public Hearing held.
- Jan 17Referred to Behavioral Health and Health Care.Minor
- Jan 13First reading. Referred to Speaker's desk.Introduced